CARL L GORDON Transaction History

Date Transaction Value Shares Traded Form
Apr 22 2019
BUY
Open market or private purchase
$6,480,000 $18.0 p/Share
360,000
Apr 22 2019
BUY
Conversion of derivative security
-
1,667,550

Also insider at

KNTE
Kinnate Biopharma Inc. Healthcare
PRVL
Prevail Therapeutics Inc.
TERN
Terns Pharmaceuticals, Inc. Healthcare
ACET
Adicet Bio, Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
KROS
Keros Therapeutics, Inc. Healthcare
GMTX
Gemini Therapeutics, Inc. Healthcare
THRX
Theseus Pharmaceuticals, Inc. Healthcare
CMPX
Compass Therapeutics, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
MBX
MBX Biosciences, Inc.
CLG

Carl L Gordon

Director
San Diego, CA

Track Institutional and Insider Activities on TPTX

Follow Turning Point Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

News

Receive news related to Turning Point Therapeutics, Inc.

Track Activities on TPTX